Is Biostage, Inc. (BSTG) a Buy, Sell, or Hold?
OTC : BSTG
Biostage, Inc. — News
$4.03 USD
$0.03 (0.75%)
- Volume
- 4.53K
- Average Volume
- 1.02K
- Market Capitalization
- $57.82M
- P/E Ratio
- -9.83
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $9.00
- Year Low
- $3.65
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.53
| Source | Headline |
|---|---|
|
Contrasting Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Biostage (OTCMKTS:BSTG)
Defiance Daily Target 2X Long LMND ETF (NASDAQ: LMNX - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Volatility and Risk defenseworld.net - 2026-04-26 03:07:02 |
